![George Golumbeski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
George Golumbeski
Chairman at
ACUMEN PHARMACEUTICALS, INC.
Net worth: 324 947 $ as of 31/05/2026
Profile
George S.
Golumbeski is currently Chairman at Carrick Therapeutics UK Ltd., Verseau Therapeutics, Inc., Actio Biosciences, Inc., National Audubon Society, Inc., Carrick Therapeutics, Inc., and Acumen Pharmaceuticals, Inc. He serves as Independent Chairman at Shattuck Labs, Inc., Non-executive Director at Faron Pharmaceuticals Oy, and Director at Corbus Pharmaceuticals, Inc., BlackThorn Therapeutics, Inc., Tusk Therapeutics Ltd., and Peptone Ltd. He is a Trustee at Keck Graduate Institute of Applied Life Sciences, Partner at Droia Ventures, and Venture Advisor at Vertex Ventures HC.
Former roles include Chief Executive Officer at Nabriva Therapeutics GmbH, Chairman at Aura Biosciences, Inc., BioSight Ltd., and Ananke Therapeutics, Inc., Deputy Chairman-Supervisory Board at MorphoSys AG, Independent Director at SAGE Therapeutics, Inc., Independent Director at Enanta Pharmaceuticals, Inc., President & Director at GRAIL, Inc., Director at Tizona Therapeutics, Inc., KSQ Therapeutics, Inc., and Chroma Medicine, Inc., Director-Business Development at Pierce Biotechnology, Inc., Vice President & Director-Corporate Development at Schwarz Pharma, Inc., Senior Director-Licensing at EMD Pharmaceuticals, Inc., Independent Director at Acceleron Pharma, Inc., Director at Corbus Pharmaceuticals Holdings, Inc., Vice President-Business Development at Elan Pharmaceuticals LLC, Executive Vice President-Innovation at Celgene Corp., VP-Business Development, Licensing & Strategy at Novartis Oncology, Inc., and Manager-Technology Acquisition at Promega Corp.Education includes a doctorate from the University of Wisconsin conferred in 1985 and an undergraduate degree from the University of Virginia conferred in 1979.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SHATTUCK LABS, INC. 0.07% | 29/05/2026 | 54,613 ( 0.07% ) | 324 947 $ | 31/05/2026 |
| 03/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
George Golumbeski active positions
| Companies | Position | Start |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Chairman | 06/11/2025 |
| SHATTUCK LABS, INC. | Chairman | 22/10/2021 |
| FARON PHARMACEUTICALS OY | Director/Board Member | 05/05/2026 |
Corbus Pharmaceuticals, Inc.
 Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director/Board Member | - |
Vertex Ventures HC
 Vertex Ventures HC Investment ManagersFinance Vertex Ventures invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, medical and technology sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | 20/10/2020 |
Actio Biosciences, Inc.
 Actio Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for rare diseases | Chairman | - |
Peptone Ltd.
 Peptone Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and provides business, domestic software development, data processing, hosting and biotechnology research and development services | Director/Board Member | - |
DROIA NV
 DROIA NV Investment ManagersFinance Droia Ventures invests in companies located across the globe. The firm focuses on oncology and gentic disease related drug development companies. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01/10/2020 |
Verseau Therapeutics, Inc.
 Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides immuno-therapy services | Chairman | 20/10/2019 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Former positions of George Golumbeski
| Companies | Position | End |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of George Golumbeski
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
87
1st degree connections
39
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 39 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Acumen Pharmaceuticals, Inc.
 Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Elan Pharmaceuticals LLC
 Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Corbus Pharmaceuticals, Inc.
Corbus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Audubon Society, Inc.
 National Audubon Society, Inc. Miscellaneous Commercial ServicesCommercial Services Conserves and restores natural ecosystems | Commercial Services |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Promega Corp.
 Promega Corp. BiotechnologyHealth Technology Manufactures enzymes and other products for biotechnology and molecular biology | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Faron Pharmaceuticals Oy
 Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Keck Graduate Institute of Applied Life Sciences
 Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Schwarz Pharma, Inc.
 Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products | Health Technology |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
BioSight Ltd.
 BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Health Technology |
Pierce Biotechnology, Inc.
 Pierce Biotechnology, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
SAGE Therapeutics, Inc.
 SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Health Technology |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
DROIA NV
DROIA NV Investment ManagersFinance Droia Ventures invests in companies located across the globe. The firm focuses on oncology and gentic disease related drug development companies. It provides financing for seed and early stage capital requirements. | Finance |
Carrick Therapeutics Ltd.
 Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for oncological therapy treatment | Health Technology |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
GRAIL, Inc.
 GRAIL, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection test kits and provides related services | Health Technology |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Health Technology |
Verseau Therapeutics, Inc.
Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides immuno-therapy services | Commercial Services |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, medical and technology sectors. It provides financing for early stage capital requirements. | Finance |
Peptone Ltd.
Peptone Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and provides business, domestic software development, data processing, hosting and biotechnology research and development services | Health Technology |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
Carrick Therapeutics UK Ltd.
 Carrick Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of cancer therapies | Commercial Services |
Actio Biosciences, Inc.
Actio Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for rare diseases | Health Technology |
Ananke Therapeutics, Inc.
 Ananke Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic medicines for patients | Health Technology |
- Stock Market
- Insiders
- George Golumbeski
